Adicet Bio
ACET
ACET
54 hedge funds and large institutions have $266M invested in Adicet Bio in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 21 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
23% more funds holding
Funds holding: 44 → 54 (+10)
16% more ownership
Funds ownership: 48.58% → 64.58% (+16%)
Holders
54
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$29.2M | |
| 2 | +$21M | |
| 3 | +$15.9M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$13.7M |
| 5 |
VA
VR Adviser
New York
|
+$13.1M |
Top Sellers
| 1 | -$1.82M | |
| 2 | -$513K | |
| 3 | -$362K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$318K |
| 5 |
Morgan Stanley
New York
|
-$193K |